XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
2. SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Service Fee Revenue

The Company’s total net revenues during the three months ended March 31, 2018 and 2017 have been presented in the table based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):

 

    Three Months Ended  
    March 31,  
    2018     2017  
             
Commercial insurance   $ 136,415     $ 140,995  
Medicare     45,609       47,678  
Medicaid     6,258       6,733  
Workers' compensation/personal injury     8,724       9,057  
Other (1)     7,162       8,287  
Service fee revenue, net of contractual allowances and discounts     204,168       212,750  
Provision for bad debts           (11,646 )
Net service fee revenue     204,168       201,104  
Revenue under capitation arrangements     27,224       27,909  
Total net revenue   $ 231,392     $ 229,013  

_____________________

 (1) Other consists of revenue from teleradiology services, consulting fees and software revenue.

Schedule of goodwill and other intangible assets

Activity in goodwill for the three months ended March 31, 2018 is provided below (in thousands):

 

Balance as of December 31, 2017   $ 256,776  
 Goodwill acquired through the acquisition of Imaging Services Company of New York, LLC     2,692  
 Goodwill acquired through the acquisition of MemorialCare Medical Foundation     10,158  
 Goodwill transferred to assets held for sale     (1,059 )
Balance as of March 31, 2018   $ 268,567  

Fair value of derivatives

The fair value of derivative instruments as of March 31, 2018 is as follows (amounts in thousands):

 

For the three months ended March 31, 2018

 

Derivatives   Balance Sheet Location   Fair Value – Asset Derivatives  
Interest rate contracts   Current assets   $ 3,552  

Effect of derivative instruments on comprehensive income

A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss is as follows (amounts in thousands):

 

For the three months ended March 31, 2018

 

Account  Jan 1 2018 Balance   Amount of gain recognized on derivative   March 31 2018 Balance   Location
Other Comprehensive (Loss) Income   (370)   3,095    2,725   Liabilities & Equity

 

For the twelve months ended December 31, 2017

         

Account  Jan 1 2017 Balance   Amount of loss recognized on derivative   Dec 31 2017 Balance   Location
Other Comprehensive Income (Loss)   510    (880)   (370)   Liabilities & Equity

 

Schedule of fair value of assets and liabilities

The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our consolidated balance sheets, as follows (in thousands):

 

    As of March 31, 2018  
    Level 1     Level 2     Level 3     Total  
Current and other non-current liabilities                                
Interest Rate Contracts   $     $ 3,552     $     $ 3,552  

 

      As of December 31, 2017  
      Level 1       Level 2       Level 3       Total   
Current assets                                
Interest Rate Contracts   $     $ (595 )   $     $ (595 )
Schedule of fair value and carrying amount of our long-term debt

The table below summarizes the estimated fair value and carrying amount of our long-term debt as follows (in thousands):

 

    As of March 31, 2018  
    Level 1     Level 2     Level 3     Total Fair Value     Total Face Value  
First Lien Term Loans   $     $ 620,417     $     $ 620,417     $ 612,002  

 

    As of December 31, 2017  
    Level 1     Level 2     Level 3     Total Fair Value     Total Face Value  
First Lien Term Loans   $     $ 628,801     $     $ 628,801     $ 620,272  
Earnings per share

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

 

    Three Months Ended March 31,  
    2018     2017  
             
Net loss attributable to RadNet, Inc. common stockholders   $ (7,338 )   $ (1,210 )
                 
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS                
Weighted average number of common shares outstanding during the period     47,822,618       46,560,017  
Basic and diluted net loss per share attributable to RadNet, Inc. common stockholders   $ (0.15 )   $ (0.03
Investment in joint ventures

The following table is a summary of our investment in joint ventures during the quarter ended March 31, 2018 (in thousands):

 

Balance as of December 31, 2017   $ 52,435  
Equity in earnings in these joint ventures     2,977  
Distribution of earnings     (2,821 )
Balance as of March 31, 2018   $ 52,591  
Joint venture investment and financial information

The following table is a summary of key balance sheet data for these joint ventures as of March 31, 2018 and December 31, 2017 and income statement data for the three months ended March 2018 and 2017 (in thousands):

 

Balance Sheet Data:   March 31, 2018     December 31, 2017  
Current assets   $ 45,486     $ 47,813  
Noncurrent assets     107,001       107,481  
Current liabilities     (16,162 )     (16,655 )
Noncurrent liabilities     (39,836 )     (42,072 )
Total net assets   $ 96,489     $ 96,567  
                 
Book value of RadNet joint venture interests   $ 46,091     $ 45,935  
Cost in excess of book value of acquired joint venture interests     6,500       6,500  
Total value of Radnet joint venture interests   $ 52,591     $ 52,435  
                 
Total book value of other joint venture partner interests   $ 50,398     $ 50,632  

 

Income statement data for the three months ended March 31,     2018       2017  
                 
Net revenue   $ 44,546     $ 41,251  
Net income   $ 6,250     $ 4,130